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Abstract
Exposure to radon gas is the second most common cause of lung cancer after smoking. A large number of studies
have reported that exposure to indoor radon, even at low concentrations, is associated with lung cancer in the
general population. This paper reviewed studies from several countries to assess the attributable risk (AR) of lung
cancer death due to indoor radon exposure and the effect of radon mitigation thereon. Worldwide, 3–20 % of all
lung cancer deaths are likely caused by indoor radon exposure. These values tend to be higher in countries
reporting high radon concentrations, which can depend on the estimation method. The estimated number of lung
cancer deaths due to radon exposure in several countries varied from 150 to 40,477 annually. In general, the
percent ARs were higher among never-smokers than among ever-smokers, whereas much more lung cancer deaths
attributable to radon occurred among ever-smokers because of the higher rate of lung cancers among smokers.
Regardless of smoking status, the proportion of lung cancer deaths induced by radon was slightly higher among
females than males. However, after stratifying populations according to smoking status, the percent ARs were
similar between genders. If all homes with radon above 100 Bq/m3 were effectively remediated, studies in Germany
and Canada found that 302 and 1704 lung cancer deaths could be prevented each year, respectively. These
estimates, however, are subject to varying degrees of uncertainty related to the weakness of the models used and
a number of factors influencing indoor radon concentrations.
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Background
Radon is a chemically inert radioactive gas of natural ori-
gin that is produced from uranium and radium in rocks
and soils throughout the earth’s crust. Outdoors, radon is
of no concern to human health, because it is quickly di-
luted by atmospheric mixing [1]. However, radon can ac-
cumulate to harmful levels in confined spaces such as
homes and workplaces. Inhalation of high levels of radon,
a source of radioactivity, can induce DNA mutation and
increase the risk of cancer by depositing decay products in
the lung epithelium [2]. In 1988, the International Agency
for Cancer Research declared radon to be carcinogenic for
humans and classified as a proven human carcinogen [3].
Radon is the second most common cause of lung cancer
after smoking [4]. Long-term exposures to radon have
been linked to lung cancer in several epidemiological
studies [5]. In the sixteenth century, mortality from re-
spiratory disease increased among certain groups of
underground miners in Central Europe, and the primary
cause of deaths was first suspected as radon-related lung
cancer in the twentieth century [4]. Evidence on health ef-
fects of radon comes mainly from epidemiological studies
of underground miners exposed to high concentrations of
radon, which has consistently been shown to be related to
an increased risk of lung cancer for both smokers and
non-smokers [2]. Beginning in the 1980s, a large number
of studies set out to investigate associations between lung
cancer and exposure to indoor radon among the general
population. However, these studies failed to provide
definitive results, mainly because of the small number
of study participants; some showed a significant relation-
ship between indoor radon exposure and lung cancer [6],
while others did not [7]. Therefore, pooled-analyses were
undertaken to ascertain associations in the general popu-
lations of Europe, North America, and China [5, 8–11].
These collaborative analyses presented similar results on a
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positive association between indoor radon exposure and
lung cancer risk.
Indoor radon may constitue a significant and poten-
tially preventable risk factor for lung cancer. Measuring
health risks can be useful to public health policy making
and the allocation of available resources. The population
risk of radon-induced lung cancer is assessed by attribut-
able risk (AR). AR is a measure of how much of the dis-
ease risk is attributable to a certain exposure, and thus,
indicates the potential for prevention if the exposure
could be eliminated [12]. Explicitly, the AR of lung
cancer deaths due to indoor radon exposure refers to
the proportion of lung cancer deaths that could be
prevented if indoor radon concentrations were reme-
diated to outdoor levels [13]. In fact, since most
homes are deemed to have low levels of radon, the
majority of lung cancer deaths attributable to radon
would occur among persons exposed to indoor radon
concentrations below commonly used reference levels
[4]. Therefore, strategies to mitigate indoor radon
levels are necessary for public health, and quantitative
analyses would help in determining appropriate refer-
ence levels thereof. In this review, we summarized the
results of studies from several countries on ARs of
lung cancer deaths due to indoor radon exposure and
the effects of radon mitigation.
Review
Lung cancer deaths attributable to indoor radon
exposure per country
Tables 1 and 2 show the estimated percentages and
numbers of lung cancer deaths attributable to indoor
radon exposure in American, European, and Asian coun-
tries [1, 2, 14–21]. The percent AR of lung cancer deaths
due to radon exposure is estimated to be lie between
3 % (United Kingdom) and 20 % (Sweden). These calcu-
lations suggest that of all lung cancer deaths worldwide,
3–20 % may be caused by indoor radon exposure. The
number of lung cancer deaths attributed to radon expos-
ure ranges from 150 (Netherlands) to 40,477 (South
Korea). The wide variation of the estimates among coun-
tries may be due to the exposure-response relation
model used and the overall number of lung cancer
deaths in each country. These findings support that in-
door radon exposure poses a significant hazard to public
health. Indeed, radon-induced lung cancer deaths may
be greater than deaths from other cancers. As an ex-
ample, the estimated number of lung cancer deaths due
to radon exposure in the United States is greater than
the annual number of deaths for several cancers includ-
ing malignant neoplasms of the ovaries, liver, brain,
stomach, or melanoma [4].
Averaged indoor radon concentrations range from 21
to 110 Bq/m3 (arithmetic means), showing considerable
variations among countries. Although directly compar-
ing results from different epidemiological studies would
be difficult because of methodological differences, coun-
tries with high indoor radon concentrations tend to have
high estimates of percent AR for lung cancer deaths.
The highest estimate of percent AR (20 %) was reported
in a Swedish study using two-mutation carcinogenesis
model for a country-wide average radon concentration
of 110 Bq/m3 [18]. The lowest indoor radon concentra-
tion (21 Bq/m3) was measured in the UK, which also
showed the lowest percent AR (3.3 %) of lung cancer
deaths given in the model from the European pooling
study [20].
Estimates of AR are dependent on the risk model used.
Several studies have applied the models proposed by the
sixth Biological Effects of Ionizing Radiation (BEIR-VI)
Committee [2] for calculating lung cancer deaths attribut-
able to indoor radon exposure in the general population.
The BEIR-VI models were developed by reanalyzing the
initial combined analysis of 11 cohorts of miners in 1994
[22]. The committee derived two linear excess risk models
representing the multiplicative increment in the excess
lung cancer risk beyond background levels of radon
[2, 23]. Both models take into account time since expos-
ure, the attained age, and either the duration of the expos-
ure (exposure-age-duration, EAD model) or the level of
concentration (exposure-age-concentration model, EAC
model). Regardless of the chosen model, the estimated
numbers are similar, however the EAC model tends to
produce higher values than the EAD model [21]. For the
US [2] and France [16], overall percent ARs were esti-
mated higher in the EAC model than in the EAD model
(13.9 % vs. 9.8 % in the USA and 13 % vs. 9 % in France,
respectively). Accordingly, the numbers of lung cancer
deaths due to indoor radon were higher when applying
the EAC model than the EAD model: in the US, 21,800
lung cancer deaths were probably caused by indoor radon
annually in the EAC model and 15,400 in the EAD model,
with 3337 in the EAC model and 2361 in the EAD model
in France. Although estimates for overall percent AR were
not presented in research articles from Portugal [21] and
South Korea [19], a similar trend was observed in the
overall numbers of lung cancer deaths, which were calcu-
lated as a summation of deaths for both genders (Table 2).
A model developed by the European pooling study [8, 9]
has also been commonly used to estimate the lung can-
cer risk due to indoor radon. Unlike the BEIR-VI
models, which are subject to uncertainties because of
indirect methods extrapolating evidence from miners to
the general population [24], the European pooling study
utilized data on lung cancer and residential radon from
13 general European population case-control studies
(7,148 cases of lung cancers and 14,208 controls) [8],
consequently estimating directly lung cancer risk due to
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indoor radon exposure. The risk derived from the
European pooling study was adjusted for age, gender, re-
gion of residence, and smoking status. The model of the
European pooling study tends to produce lower ARs than
the BEIR-VI models. In France, a 5 % (1234 lung cancer
deaths) AR was calculated using the model of the
European pooling study, regardless of gender and smok-
ing status, which is lower than estimates calculated by
the BEIR-VI models [16]. The Advisory Group on Ionis-
ing Radiation also reported similar trends in the UK,
with percent ARs of 3.0 % using the European pooling
study model and 6.0 % using the BEIR-VI model [20]. In
South Korea, both males and females showed lower
estimates of AR using the European pooling study
model than with using the BEIR-VI models [19]. These
discrepancies may be due to overestimation of the rele-
vant exposure in older age groups and due to the lack of
correction for uncertainties in radon distribution in the
BEIR-VI models [14].
Leenhouts and Brugmans [18] applied a two-mutation
carcinogenesis model for calculating ARs in the
Netherlands and Sweden. This model has previously
been used in a number of animal experiments and in
a study by Leenhouts [25] to examine the induction
of lung cancer by smoking and radon exposure. The
model assumes that two mutations play a role in the





Model used in risk estimation Ever-smokers Never-smokers Ever- and never-smokers
Male Female Total Male Female Total Male Female Total
United States
([2], 1999) 46 BEIR VI, EAC 12.5 13.7 12.9 25.8 26.9 26.4 14.1 15.3 13.9
BEIR VI, EAD 8.7 9.6 9.1 18.9 19.7 19.1 9.9 10.8 9.8
Netherlands
([18], 2001) 23 Two-mutation carcinogenesis model - - - - - - 2 6 4
Sweden
([18], 2001) 110 Two-mutation carcinogenesis model - - - - - - 17 24 20
Canada
([15], 2005) 28 BEIR VI, EAC - - 7.3 - - 13.5 - - 7.8
([1], 2012) 42 EPA model 15.3 14.3 14.8 29.5 27.8 28.4 16 16 16
([17], 2013) 43 BEIR VI, EAC - - 12.3 - - 21.9 - - 13.6
France
([16], 2006) 89 BEIR VI, EAC - - 11 - - 50 - - 13
BEIR VI, EAD - - 8 - - 36 - - 9
European pooling study - - - - - - - - 5
Germany
([14], 2008) 49 European pooling study 5.0 5.2 - 5.2 5.2 - - - 5.0
Switzerland
([14], 2008) 78 European pooling study 8.2 8.6 - 8.8 8.8 - - - 8.3
United Kingdom
([20], 2009) 21 BEIR VI, EAC - - - - - - - - 6.0
European pooling study - - - - - - - - 3.3
Portugal
([21], 2012) 81 BEIR VI, EAC 25 23 - 40 38 - 27 34 -
BEIR VI, EAD 18 17 - 31 29 - 20 27 -
South Korea
([19], 2015) 62 BEIR VI, EAC 18.6 18.5 - 33.2 32.8 - 19.5 28.2 -
BEIR VI, EAD - - - - - - 13.5 20.4 -
European pooling study - - - - - - 8.3 8.3 -
The values not presented in papers were left blank
EAC exposure-age-concentration model, EAD exposure-age-duration model, EPA Environmental Protection Agency
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transformation of a normal somatic stem cell to a malig-
nant cell and the effects of radon exposure and smoking
are caused by changes in mutation rates [26]. Chen et al.
[1] used a model proposed by the US Environmental
Protection Agency (EPA model). This model was devised
as a single model from two BEIR-VI models (EAC and
EAD models) by assigning risk values midway between
the two models [23], since both are equally preferred
and it is difficult to choose only one in practice [2]. The
two-mutation carcinogenesis model and the EPA model
have not been used as commonly as the BEIR-VI models
and that from the European pooling study. Furthermore,
the two-mutation carcinogenesis model and EPA model
were used respectively in each study, and thus, it is
impossible to directly compare their AR estimates with
those from the other models.
Attributable risk according to smoking status and gender
Active smoking became the most common cause of lung
cancer during the 20th century [27], and several studies
have been established that approximately 90 % of all
lung cancers occur among smokers [27–31]. Thus, con-
sidering the possible interaction with smoking is import-
ant when investigating the effect of radon exposure on
lung cancer risk.
In general, never-smokers are affected more by radon
exposure than smokers, but the absolute risk is higher





Model used in risk estimation Ever-smokers Never-smokers Ever- and never-smokers
Male Female Total Male Female Total Male Female Total
United States
([2], 1999) 46 BEIR VI, EAC 11300 7600 18900 1200 1700 2900 12500 9300 21800
BEIR VI, EAD 7900 5400 13300 900 1200 2100 8800 6600 15400
Netherlands
([18], 2001) 23 Two-mutation carcinogenesis model - - - - - - 90 60 150
Sweden
([18], 2001) 110 Two-mutation carcinogenesis model - - - - - - 242 178 420
Canada
([15], 2005) 28 BEIR VI, EAC - - - - - - - - 1400
([1], 2012) 42 EPA model 1639 1198 2837 166 258 424 1805 1456 3261
([17], 2013) 43 BEIR VI, EAC - - 708 - - 139 - - 847
France
([16], 2006) 89 BEIR VI, EAC - - 2578 - - 759 - - 3337
BEIR VI, EAD - - 1819 - - 541 - - 2361
European pooling study - - - - - - - - 1234
Germany
([14], 2008) 49 European pooling study 1390 347 1737 32 127 159 1422 474 1896
Switzerland
([14], 2008) 78 European pooling study 164 54 218 5 8 13 169 62 231
United Kingdom
([20], 2009) 21 BEIR VI, EAC - - - - - - 1156 888 2044
European pooling study - - - - - - 637 473 1100
Portugal
([21], 2012) 81 BEIR VI, EAC 1627 308 1935 143 60 203 1769 369 2138
BEIR VI, EAD 1183 226 1409 111 46 157 1294 271 1565
South Korea
([19], 2015) 62 BEIR VI, EAC - - - - - - 26782 13695 40477
BEIR VI, EAD - - - - - - 18614 9947 28561
European pooling study - - - - - - 11906 4271 16177
The values not presented in papers were left blank
EAC exposure-age-concentration model, EAD exposure-age-duration model, EPA Environmental Protection Agency
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for smokers than for never-smokers, because of the
higher lung cancer rate among smokers [2, 23, 32, 33].
As for the AR of lung cancer deaths due to indoor
radon, attributable percentages were higher for never-
smokers than ever-smokers; however, greater number of
lung cancer deaths due to radon exposure occurred in
ever-smokers than in never-smokers (Tables 1 and 2).
For example, in the US, the percent ARs of lung cancer
deaths due to indoor radon exposure for both genders
ranged from 19.1 to 26.4 % among never-smokers and
9.1–12.9 % among ever-smokers, whereas the number of
lung cancer deaths reached 2100–2900 for never-
smokers and 13,300–18,900 for ever-smokers [2]. Stud-
ies in Canada [1, 17] and France showed similar results.
Even after analyzing separately by gender, this trend
remained consistent in several studies from various
countries [1, 2, 14, 21].
In several epidemiological studies, percent ARs have
been estimated to be slightly higher for females than for
males regardless of smoking status (Table 1). However,
the differences in the attributable percentages between
genders were similar after stratifying populations accord-
ing to smoking status. These results may be due to the
lower proportion of female smokers compared to male
smokers in most countries. The estimated numbers of
lung cancer deaths attributable to radon exposure among
both ever- and never-smokers were higher for males than
for females (Table 2). This is likely due to the high smok-
ing rates in males, and thus, the overall number of lung
cancer deaths was higher in males than in females. Only
for never-smokers, namely under the condition of exclud-
ing influence by smoking, more radon-induced lung can-
cer deaths occurred among females than among males in
most studies.
Effects of indoor radon mitigation
The measured indoor radon levels follow a lognormal
distribution in general. In other words, most individuals
are exposed to low concentrations of radon in their
homes. Evidence from studies on general populations
suggests that chronic exposure to radon at low doses
can cause lung cancer [8, 34]. Therefore, it is needed to
reduce the indoor radon concentrations to lower level to
prevent more lung cancers due to radon exposure.
Table 3 shows the estimated percentages and numbers
of lung cancer deaths attributable to radon that could be
prevented if all homes above given radon concentrations
were effectively remediated. The effects of radon mitiga-
tion on lung cancer were assessed in studies conducted
in the US [2], Germany [14], and Canada [1, 17]. In the
US, under the EAC model, mitigating radon levels in
homes at or above 148 Bq/m3, the EPA action level [13],
would result in an estimated reduction in lung cancer
mortality of 4.2 % if indoor radon were completely elimi-
nated, 3.7 % if homes were mitigated to 0–148 Bq/m3,
or 1.7 % if homes were remediated to exactly 148 Bq/m3
[2]. In Germany, reducing radon levels below 100 Bq/m3
(WHO guideline [4]) in homes would prevent 302 lung
cancer deaths (15.9 % of all lung cancer deaths attribut-
able to radon) every year [14]. At mitigation levels of
200 and 400 Bq/m3 (European action level for new and
old houses), 143 (7.5 %) and 68 (3.6 %) deaths could be
potentially avoided, respectively. In Canada, out of total
3261 radon-induced lung cancer deaths nationwide,
1704 (52.3 %) can be prevented per year if all homes
with radon above 100 Bq/m3 were remediated to out-
door levels, and 927 (28.4 %) at the Canadian action
level of 200 Bq/m3 [1]. Additionally, it was predicted
that reducing indoor radon levels to outdoor level for all





Mitigation level of indoor radon concentration
Radon-attributable lung cancer deaths (n, %) that can be prevented
United States 37 Bq/m3 74 Bq/m3 148 Bq/m3
([2], 1999) BEIR-VI, EAC 0 11.0 % 7.8 % 4.2 %
< Mitigation level 9.2 % 6.5 % 3.7 %
Mitigation level 6.8 % 4.0 % 1.7 %
BEIR-VI, EAD 0 7.7 % 5.5 % 3.1 %
< Mitigation level 6.5 % 4.7 % 2.7 %
Mitigation level 4.9 % 2.8 % 1.2 %
Germany 100 Bq/m3 150 Bq/m3 200 Bq/m3 250 Bq/m3 400 Bq/m3
([14], 2008) European pooling study 9 (outdoor level) 302, 15.9 % 197, 10.4 % 143, 7.5 % 115, 6.1 % 68, 3.6 %
Canada 100 Bq/m3 200 Bq/m3 400 Bq/m3 600 Bq/m3 800 Bq/m3
([1], 2012) EPA model outdoor level 1704, 52.3 % 927, 28.4 % 345, 10.6 % 165, 5.1 % 90, 2.8 %
Ontario, Canada 50 Bq/m3 100 Bq/m3 150 Bq/m3 200 Bq/m3
([17], 2013) BEIR-VI, EAC 10–30 389, 46 % 233, 28 % 149, 18 % 91, 11 %
EAC exposure-age-concentration model, EAD exposure-age-duration model, EPA Environmental Protection Agency
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homes above 100 and 200 Bq/m3 would prevent 233
(28 %) and 91 (11 %) radon-attributable lung cancer
deaths, respectively, in Ontario, Canada [17].
The results from several studies suggest that setting
mitigation levels of indoor radon lower can prevent more
lung cancer deaths. Therefore, strategies for radon re-
mediation are needed to reduce the risk of radon-related
lung cancer. Such strategies should consider technological
difficulties, success rates, and costs, because radon sources
and radon transport mechanisms may have a considerable
influence on the cost-effectiveness [4].
Uncertainty
There are many sources of uncertainty in estimating AR.
These uncertainties stem mainly from the weakness of
the model used and the various factors influencing in-
door radon concentrations.
The BERI-VI models have several sources of uncer-
tainty [2]. Among these sources, extrapolation of results
from the studies of miners to assess the risk of lung can-
cer for general populations is a critical issue of uncer-
tainty. Using exposure-response relations determined
among underground miners to assess the risk in the
general population underlines some of the differences
between these two populations [16]. Miners are gener-
ally exposed to higher levels of radon than the general
population. Sex and age distributions are also different
between both populations: miners are almost all men of
working age, whereas the general population comprises
men and women of all ages. Exposure and risk can also
be modified by various physical and biological factors
such as ventilator flow, breathing frequency, tracheo-
bronchial configuration, and an individual’s physical size
[21]. Moreover, smoking-related risks in miners have
been reported to be different from those in the general
population, and many miners are exposed to various car-
cinogens other than radon, such as arsenic [4]. Despite
these uncertainties, most studies have had to assume
that the lung cancer risk due to exposure to indoor
radon is close to that observed among miners, because
of a lack of appropriate data.
The two-mutation carcinogenesis model also has some
weaknesses [18]. This model is a simplification of the de-
velopment of lung cancer caused by smoking and radon
exposure, but the real process is more complex. Further-
more, there are a large number of parameters that have
to be determined when fitting the model to data, and pa-
rameters are assumed to be dependent on exposure to
external agents, but not on age. These imply statistical
uncertainties in the parameters, which are difficult to
quantify, because of the interplay between the parame-
ters and model assumptions.
The estimation of indoor radon concentrations is also
associated with numerous uncertainties. Indoor radon
concentrations depend on various factors, such as the
soil, building materials, house type, and ventilation.
Therefore, concentrations can vary between houses and
even from room to room in the same house due to some
conditions such as ventilation practices [8, 35]. Indoor
radon concentrations also vary substantially between and
within regions [36]. Seasons are related to variations in
radon concentrations within homes, with the highest
levels in winter and the lowest in summer. As well, annual
average radon concentrations are subject to substantial
random year-to-year variations related to numerous fac-
tors such as weather patterns and occupant behaviors [4].
The uncertainties introduced by these factors need to be
addressed adequately using statistical corrections.
Additionally, methodological issues for measurements
are sources of uncertainty in estimating indoor radon con-
centrations. Potential radon exposure misclassification can
arise from detector’s measurement errors and localization
choices within a home, inaccessible data on previously oc-
cupied homes, failure to link radon concentrations with
subject mobility, and measuring radon gas concentration
as a surrogate for radon progeny exposure [37]. Unfortu-
nately, the impact of these uncertainties on AR estimations
is very difficult to quantify. However, if the misclassification
were to be non-differential between cases and controls, the
observed results tend to be underestimated.
Conclusions
Radon is the great public health threat conveyed by in-
door air. Epidemiological studies have confirmed that
radon in homes increases the risk of lung cancer in the
general population. Among the carcinogens of lung can-
cer, radon is the second leading cause after smoking. Of
all lung cancer deaths, from 3 to 20 % are attributable to
indoor radon exposure worldwide, depending on the
average radon concentration in the country and on the
method of calculation. Radon is much more likely to
cause lung cancer in ever-smokers than in never-
smokers, but it is the primary cause of lung cancer
among never-smokers. A large portion of radon-induced
lung cancer deaths are caused by radon concentrations
below commonly used reference levels, because the ma-
jority of general population are exposed to low and
moderate level of indoor radon. These observations
imply that effective measures to prevent and reduce in-
door radon concentrations should be developed and in-
cluded in national radon control programs.
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